open access

Vol 11, No 1 (2018)
Review paper
Published online: 2018-04-26
Get Citation

Selected topics on the current state of non-invasive diagnosis of foetal blood groups in the light of reports presented at the 3rd International Meeting on Cell-Free DNA

Agnieszka Orzińska
Journal of Transfusion Medicine 2018;11(1):29-32.

open access

Vol 11, No 1 (2018)
REVIEWS
Published online: 2018-04-26

Abstract

Selected topics on the current state of non-invasive diagnosis of foetal blood groups in the light of reports presented at the 3rd International Meeting on Cell-Free DNA

Abstract

Selected topics on the current state of non-invasive diagnosis of foetal blood groups in the light of reports presented at the 3rd International Meeting on Cell-Free DNA
Get Citation

Keywords

Selected topics

About this article
Title

Selected topics on the current state of non-invasive diagnosis of foetal blood groups in the light of reports presented at the 3rd International Meeting on Cell-Free DNA

Journal

Journal of Transfusion Medicine

Issue

Vol 11, No 1 (2018)

Article type

Review paper

Pages

29-32

Published online

2018-04-26

Bibliographic record

Journal of Transfusion Medicine 2018;11(1):29-32.

Keywords

Selected topics

Authors

Agnieszka Orzińska

References (18)
  1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997; 350(9076): 485–487.
  2. Orzińska A, Guz K, Dębska M, et al. 14 Years of Polish Experience in Non-Invasive Prenatal Blood Group Diagnosis. Transfus Med Hemother. 2015; 42(6): 361–364.
  3. Sillence KA, Roberts LA, Hollands HJ, et al. Fetal Sex and RHD Genotyping with Digital PCR Demonstrates Greater Sensitivity than Real-time PCR. Clin Chem. 2015; 61(11): 1399–1407.
  4. Wienzek-Lischka S, Krautwurst A, Fröhner V, et al. Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing. Transfusion. 2015; 55(6 Pt 2): 1538–1544.
  5. Clausen FB, Christiansen M, Steffensen R, et al. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion. 2012; 52(4): 752–758.
  6. Stegmann TC, Veldhuisen B, Bijman R, et al. Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women. Br J Haematol. 2016; 173(3): 469–479.
  7. Haimila K, Sulin K, Kuosmanen M, et al. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland. Acta Obstet Gynecol Scand. 2017; 96(10): 1228–1233.
  8. de Haas M, Thurik FF, van der Ploeg CPB, et al. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands. BMJ. 2016; 355: i5789.
  9. Clausen FB, Barrett AN, Krog GR, et al. Non-invasive foetal RhD genotyping to guide anti-D prophylaxis:an external quality assurance workshop. Blood Transfus. 2017 [Epub ahead of print]: 1–5.
  10. Hawk AF, Chang EY, Shields SM, et al. Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis. Obstet Gynecol. 2013; 122(3): 579–585.
  11. Teitelbaum L, Metcalfe A, Clarke G, et al. Costs and benefits of non-invasive fetal RhD determination. Ultrasound Obstet Gynecol. 2015; 45(1): 84–88.
  12. Johnson JA, MacDonald K, Clarke G, et al. No. 343-Routine Non-invasive Prenatal Prediction of Fetal RHD Genotype in Canada: The Time is Here. J Obstet Gynaecol Can. 2017; 39(5): 366–373.
  13. Gordon LG, Hyland C, Hyett J, et al. Non-invasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: a cost-effectiveness analysis. Prenat Diagn. 2017 [Epub ahead of print].
  14. https://nonacus.com/support/.
  15. Javadi A, Veldhuisen B, de Ha, et al. Evaluation of phorcine herpesvirus (PHHV) as an internal control for prenatal RHD genotyping in maternal plasma. Vox Sang. 2016; 111: 246.
  16. Zelinski T, Coghlan G, Liu XQ, et al. ABCG2 null alleles define the Jr(a-) blood group phenotype. Nat Genet. 2012; 44(2): 131–132.
  17. McBean RS, Hyland CA, Hendry JL, et al. SARA: a "new" low-frequency MNS antigen (MNS47) provides further evidence of the extreme diversity of the MNS blood group system. Transfusion. 2015; 55(6 Pt 2): 1451–1456.
  18. Mo ller M, Jo ud M, Storry JR, et al. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Advances. 2016; 1(3): 240–249.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Journal of Transfusion Medicine dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl